Health Care and Social Assistance

Sector Overview

The Health Care and Social Assistance sector is a crucial pillar of the economy, dedicated to delivering health care services, social assistance, and wellness programs to various populations. It includes hospitals, physicians' offices, nursing facilities, outpatient care centers, and home health care services, as well as social services that support individuals in need. Major players in this sector include a mix of for-profit and nonprofit organizations that cater to the diverse needs of patients, from acute care to preventive services.

Key drivers of growth in this sector include an aging population, advancements in medical technology, and an increasing focus on preventive care and wellness. Rising healthcare costs and demand for personalized medicine are shaping how companies operate, leading to innovations in patient care delivery and management. The sector also faces challenges such as regulatory changes, health care policy reforms, and shifts in consumer preference towards telehealth services and integrated care models, which are becoming more prevalent amidst the ongoing digital transformation in health care.

The significance of the Health Care and Social Assistance sector cannot be overstated, as it directly impacts the quality of life for individuals and communities. As global health issues such as chronic diseases and pandemics persist, the ability of this sector to adapt and innovate will be critical in promoting health equity and improving patient outcomes. Furthermore, with increased investment in research and development, including biotechnology and pharmaceuticals, the sector is poised to continue fulfilling vital roles in public health, health management, and community support.

Key Metrics

*Weighted by Market Cap Last updated: Jun 21, 2026
Avg P/E Ratio 22.8
Profitable Companies 84%
Avg Growth 19.5%
Avg Dividend Yield 0.61%

Historical Return

Last updated: Jun 15, 2026
1 Year +26.7% +0.6% Div
3 Years Ø +18.0% +0.6% Div
5 Years Ø +6.8% +0.6% Div
1 Year +143.1% +0.6% Div
3 Years Ø +19.2% +0.6% Div
5 Years Ø -5.7% +0.6% Div

Risk & Analysis Metrics

Last updated: Jun 21, 2026

Volatility

410.84% 1 Year
236.48% 3 Years
191.91% 5 Years
152.33% 10 Years

Max Drawdown

-10.41% 1 Year
-17.43% 3 Years
-32.96% 5 Years
-43.74% 10 Years

Sharpe Ratio

1.09 1 Year
0.65 3 Years
0.50 5 Years
0.54 10 Years

Volatility

14959.07% 1 Year
8591.68% 3 Years
6831.49% 5 Years
6341.30% 10 Years

Max Drawdown

-12.59% 1 Year
-25.67% 3 Years
-56.30% 5 Years
-48.83% 10 Years

Sharpe Ratio

1.03 1 Year
0.61 3 Years
0.48 5 Years
0.33 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 -6.0% 5.8% 15.8% 20.9% 15.5% 14.4% 13.9% 15.0% 17.9% 19.7% 20.0% 16.6% 16.9% 17.1% 18.1%
2012 19.1% 28.6% 31.4% 21.6% 19.0% 17.6% 18.3% 21.3% 22.9% 23.0% 18.9% 19.0% 19.0% 20.0%
2013 38.8% 38.0% 22.4% 19.0% 17.2% 18.2% 21.7% 23.4% 23.4% 18.9% 19.0% 19.0% 20.1%
2014 37.3% 15.0% 13.1% 12.4% 14.4% 19.0% 21.3% 21.6% 16.8% 17.2% 17.4% 18.6%
2015 -3.7% 2.6% 5.1% 9.3% 15.7% 18.9% 19.5% 14.5% 15.2% 15.6% 17.1%
2016 9.2% 9.8% 14.1% 21.1% 24.0% 23.9% 17.3% 17.8% 17.9% 19.4%
2017 10.5% 16.5% 25.3% 27.9% 27.0% 18.7% 19.0% 19.0% 20.5%
2018 23.0% 33.4% 34.4% 31.6% 20.5% 20.5% 20.3% 21.9%
2019 44.8% 40.4% 34.6% 19.9% 20.1% 19.9% 21.7%
2020 36.3% 29.7% 12.6% 14.6% 15.5% 18.2%
2021 23.5% 2.3% 8.1% 10.8% 14.9%
2022 -15.3% 1.2% 6.8% 12.9%
2023 20.8% 20.0% 24.2%
2024 19.1% 25.9%
2025 33.1%
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2011 - - - - - - - - - - - - - - -
2012 - - - - - - - - - - - - - -
2013 - - - - - - - - - - - - -
2014 - - - - - - - - - - - -
2015 -10.4% -1.5% 1.6% 5.2% 8.2% 12.8% 21.6% 14.7% 13.0% 15.4% 20.6%
2016 8.4% 8.2% 11.0% 13.4% 18.1% 28.0% 18.8% 16.3% 18.7% 24.2%
2017 7.9% 12.3% 15.2% 20.6% 32.3% 20.7% 17.5% 20.0% 26.1%
2018 17.0% 19.0% 25.2% 39.2% 23.4% 19.1% 21.8% 28.6%
2019 21.0% 29.5% 47.5% 25.0% 19.6% 22.7% 30.3%
2020 38.5% 62.9% 26.4% 19.2% 23.0% 31.9%
2021 91.6% 20.8% 13.4% 19.4% 30.6%
2022 -23.9% -12.8% 2.0% 18.7%
2023 -0.1% 18.1% 37.7%
2024 39.5% 61.6%
2025 87.3%

Distributions

Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%
18%
1y 3y N/A N/A
0 - 5%
42%
1y 3y N/A N/A
5 - 10%
25%
1y 3y N/A N/A
10 - 15%
4%
1y 3y N/A N/A
15 - 20%
11%
1y 3y N/A N/A
20 - 30%
0%
1y 3y N/A N/A
30 - 40%
0%
1y 3y N/A N/A
> 40%
0%
1y 3y N/A N/A
< 0%
55%
1y 3y N/A N/A
0 - 5%
12%
1y 3y N/A N/A
5 - 10%
21%
1y 3y N/A N/A
10 - 15%
3%
1y 3y N/A N/A
15 - 20%
5%
1y 3y N/A N/A
20 - 30%
0%
1y 3y N/A N/A
30 - 40%
2%
1y 3y N/A N/A
> 40%
2%
1y 3y N/A N/A

P/E Ratio Distribution

< 0
18%
1y 3y N/A N/A
0 - 10
7%
1y 3y N/A N/A
10 - 15
27%
1y 3y N/A N/A
15 - 20
12%
1y 3y N/A N/A
20 - 25
13%
1y 3y N/A N/A
25 - 35
1%
1y 3y N/A N/A
35 - 50
20%
1y 3y N/A N/A
> 50
2%
1y 3y N/A N/A
< 0
58%
1y 3y N/A N/A
0 - 10
9%
1y 3y N/A N/A
10 - 15
5%
1y 3y N/A N/A
15 - 20
10%
1y 3y N/A N/A
20 - 25
7%
1y 3y N/A N/A
25 - 35
2%
1y 3y N/A N/A
35 - 50
7%
1y 3y N/A N/A
> 50
3%
1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A
Equal Weight Average Undervaluation
N/A
Undervalued
> 60%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
15 - 30%
0%
1y 3y N/A N/A
Fair (&plusmn;15%)
0%
1y 3y N/A N/A
Overvalued
15 - 30%
0%
1y 3y N/A N/A
30 - 45%
0%
1y 3y N/A N/A
45 - 60%
0%
1y 3y N/A N/A
> 60%
0%
1y 3y N/A N/A

Portfolio Concentration

*by Market Cap Last updated: Jun 15, 2026
59.0% Top 5 Holdings
76.9% Top 10 Holdings
100.0% Top 50 Holdings
100.0% Top 100 Holdings
Top 5 Companies
HCA HCA Healthcare Inc
23.5%
HUM Humana Inc.
12.5%
NTRA Natera Inc
8.3%
IQV IQVIA Holdings Inc
8.3%
WST West Pharmaceutical Services, Inc.
6.4%

Market Cap Size Distribution

Micro Cap
0.3%
1y 3y N/A N/A
Small Cap
3.4%
1y 3y N/A N/A
Mid Cap
19.5%
1y 3y N/A N/A
Large Cap
76.9%
1y 3y N/A N/A
Mega Cap
0.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B
Micro Cap
40.0%
1y 3y N/A N/A
Small Cap
18.3%
1y 3y N/A N/A
Mid Cap
25.0%
1y 3y N/A N/A
Large Cap
16.7%
1y 3y N/A N/A
Mega Cap
0.0%
1y 3y N/A N/A
Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in sector Last updated: Jun 21, 2026

Compare to
Market
Market Cap The average market value of companies in this sector. $13.1B
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 0.61 %
Beta Indicates the relationship between the price performance of a share and the market. 1.08
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 22.8
Negative P/E Ratio A negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything. -99.68
Profitable Companies 84%
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 6.06
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 3.13
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company. 4.83
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT. 8.61
Enterprise Value to Revenue Enterprise value divided by revenue. 3.31
Total Debt to Enterprise Value Total debt divided by enterprise value. 0.2
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -0.22
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. 3.35%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. +19.5%
Return on Equity Equity divided by market cap. 4.83%
Return on Assets Indicates a company's profitability in relation to its total assets. 1.83%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 5.91%

Stock Screener

Select filters to narrow down the 75 companies below

75 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap $83.23B
Dividends 0.8%
P/E Ratio 12.8
Revenue $19.1B +4.3%
Net Income $1.62B +0.6%
Profit Margin +8.5%
Employees 280K
View Stock
Market Cap $43.3B
Dividends 1.0%
P/E Ratio 38.4
Revenue $39.6B +23.5%
Net Income $1.19B -4.7%
Profit Margin +3.0%
Market Cap $33.14B
Dividends 0.0%
P/E Ratio -144.7
Revenue $697M +38.8%
Net Income -$85.1M +27.1%
Profit Margin -12.2%
Market Cap $28B
Dividends 0.0%
P/E Ratio 20.4
Revenue $4.15B +8.4%
Net Income $274M +10.0%
Profit Margin +6.6%
Market Cap $23.17B
Dividends 0.3%
P/E Ratio 43.5
Revenue $845M +21.0%
Net Income $139M +54.6%
Profit Margin +16.4%
Market Cap $14.86B
Dividends 0.0%
P/E Ratio 8.8
Revenue $5.37B +2.8%
Net Income $702M +72.9%
Profit Margin +13.1%
Market Cap $14.57B
Dividends 2.1%
P/E Ratio 15.1
Revenue $1.28B +27.0%
Net Income $512M +260.6%
Profit Margin +39.9%
Market Cap $13.34B
Dividends 0.0%
P/E Ratio 20.5
Revenue $3.42B +6.0%
Net Income $198M +21.2%
Profit Margin +5.8%
Market Cap $12.67B
Dividends 3.7%
P/E Ratio 12.4
Revenue $4.61B -5.5%
Net Income $118M -22.3%
Profit Margin +2.5%
Market Cap $9.72B
Dividends 0.8%
P/E Ratio 16.1
Revenue $1.59B +9.0%
Net Income $195M +28.4%
Profit Margin +12.3%
Market Cap $8.98B
Dividends 0.2%
P/E Ratio 24.3
Revenue $1.39B +18.4%
Net Income $99.7M +24.2%
Profit Margin +7.2%
Market Cap $8.93B
Dividends 0.0%
P/E Ratio -41.2
Revenue $203M
Net Income $601M
Profit Margin +296.0%
Employees 2.15K
View Stock
Market Cap $8.84B
Dividends 0.6%
P/E Ratio 5.7
Revenue $4.5B +9.6%
Net Income $349M +10.1%
Profit Margin +7.8%
Employees 90K
View Stock
Market Cap $7.91B
Dividends 0.0%
P/E Ratio -709.4
Revenue $608M +3.8%
Net Income -$92.1M -286.1%
Profit Margin -15.1%
Employees 181
View Stock
Market Cap $5.79B
Dividends 0.6%
P/E Ratio 23.7
Revenue $658M +1.6%
Net Income $66.3M -7.6%
Profit Margin +10.1%
Market Cap $5.29B
Dividends 0.0%
P/E Ratio 86.4
Revenue $558M -4.3%
Net Income -$1.69M -110.7%
Profit Margin -0.3%
Market Cap $4.28B
Dividends 0.0%
P/E Ratio -22.6
Revenue $0.00
Net Income -$52.8M +42.8%
Profit Margin
Market Cap $4.28B
Dividends 0.0%
P/E Ratio 48.5
Revenue $139M +21.5%
Net Income $28.7M +307.4%
Profit Margin +20.6%
Market Cap $3.38B
Dividends 0.0%
P/E Ratio 19.1
Revenue $712M +7.0%
Net Income $71.7M +88.6%
Profit Margin +10.1%
Market Cap $3.32B
Dividends 0.0%
P/E Ratio 30.7
Revenue $622M +5.2%
Net Income $67.6M +109.3%
Profit Margin +10.9%